Skip to main navigation
Header Menu
  • About Us
    • Who We Are
    • Our Team
    • Board of Directors
  • Science
    • Prescription Digital Therapeutics
    • Product Pipeline
    • Clinical Trials
    • Research
  • Products
    • reSET® & reSET-O®
    • Somryst®
  • News
    • Press Releases
    • Pear in the News
    • Pear Prescription Digital Therapeutics (PDT) Digest
  • Investors
    • IR Home
    • News & Events
    • Corporate Governance
    • Financial Information
    • Stock Information
    • Shareholder Services
  • Careers
    • Our Values
    • Our Culture
    • Open Positions
Top Links
Contact Us
Pear Therapeutics, Inc.

SEC Filing Details

IR Sub Menu - Financial Information
SEC FilingsQuarterly ResultsAnnual Reports

Document Details

Form
CORRESP
Filing Date
January 6, 2023
Document Date
January 6, 2023
Form Description
CORRESP
Filing Group
Other
Company
Pear Therapeutics, Inc.
Issuer
PEAR THERAPEUTICS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

 

Back
Pear Therapeutics, Inc.
  • Boston
    200 State Street
    Boston, MA 02109
  • San Francisco
    201 Mission Street
    San Francisco, CA 94105
Footer Email
  • Email Us
Footer Social
  • Twitter
  • LinkedIn
  • © 2023 Pear Therapeutics, Inc. All Rights Reserved.
  • Privacy Policy
  • Code of Conduct